Clinical trial
Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality: A Randomized Placebo Controlled Clinical Trial
NCT00668707 is registered in ClinicalTrials.gov with The Canadian College of Naturopathic Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality: A Randomized Placebo Controlled Clinical Trial
- Lead sponsor
- The Canadian College of Naturopathic Medicine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- November 30, 2017
- Enrollment
- 709 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer